The toolbox of designing nanoparticles for tumors

Bochu Wang, Qian Yang, Yazhou Wang

  • 1Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, PR China. wangbc2000@126.com.

Insights

Nanoparticles (NPs) offer promising cancer treatment by targeting tumor cells. Careful design considering tumor barriers is crucial for effective nanoparticle drug delivery and therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Nanoparticles (NPs) are emerging as a powerful tool for disease treatment, particularly in oncology.
  • Tumor microenvironments present unique physiological characteristics, including irregular vasculature and lack of lymphatic drainage, posing challenges for NP delivery.
  • Differences in tumor tissues necessitate tailored NP design for optimal therapeutic outcomes.

Purpose of the Study:

  • To review the barriers encountered by nanoparticles within tumor tissues.
  • To provide a design framework for nanoparticles aimed at enhancing tumor treatment efficacy.
  • To discuss the influence of particle size, shape, and surface chemistry on NP performance.

Main Methods:

  • Literature review of nanoparticle applications in tumor detection, prevention, and treatment.
  • Analysis of physiological differences between tumor and normal tissues affecting NP biodistribution.
  • Discussion of nanoparticle design strategies, including physical and chemical properties.

Main Results:

  • Identified key barriers in tumor tissues, such as irregular blood vessels, low pH, and hypoxia.
  • Highlighted the importance of particle size, shape, and surface chemistry in overcoming these barriers.
  • Reviewed current preclinical and clinical applications of NPs for cancer therapy.

Conclusions:

  • Strategic design of nanoparticles is essential to overcome tumor-specific barriers for effective cancer treatment.
  • Tailoring NP properties based on therapeutic goals, target site, and administration route can optimize drug delivery.
  • Further research and development in NP design hold significant promise for advancing cancer therapy.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
160
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K